Jayamas Medica Industri Past Earnings Performance
Past criteria checks 3/6
Jayamas Medica Industri's earnings have been declining at an average annual rate of -14%, while the Medical Equipment industry saw earnings growing at 8.1% annually. Revenues have been growing at an average rate of 1.1% per year. Jayamas Medica Industri's return on equity is 12.2%, and it has net margins of 15.7%.
Key information
-14.0%
Earnings growth rate
-10.6%
EPS growth rate
| Medical Equipment Industry Growth | 12.3% |
| Revenue growth rate | 1.1% |
| Return on equity | 12.2% |
| Net Margin | 15.7% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Jayamas Medica Industri makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,835,015 | 287,902 | 261,195 | 0 |
| 30 Jun 24 | 1,805,296 | 292,696 | 255,071 | 0 |
| 31 Mar 24 | 1,767,482 | 266,397 | 252,227 | 0 |
| 31 Dec 23 | 1,736,990 | 259,360 | 250,002 | 0 |
| 30 Sep 23 | 1,737,449 | 282,502 | 227,634 | 0 |
| 30 Jun 23 | 1,736,966 | 271,834 | 222,075 | 0 |
| 31 Mar 23 | 1,686,211 | 259,451 | 208,920 | 0 |
| 31 Dec 22 | 1,739,054 | 285,782 | 198,309 | 0 |
| 31 Mar 22 | 2,193,793 | 518,360 | 185,898 | 0 |
| 31 Dec 21 | 2,226,573 | 562,692 | 168,243 | 0 |
| 31 Dec 20 | 1,994,540 | 685,510 | 186,715 | 0 |
| 31 Dec 19 | 1,228,049 | 226,208 | 149,961 | 0 |
Quality Earnings: OMED has high quality earnings.
Growing Profit Margin: OMED's current net profit margins (15.7%) are lower than last year (16.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: OMED's earnings have declined by 14% per year over the past 5 years.
Accelerating Growth: OMED's earnings growth over the past year (1.9%) exceeds its 5-year average (-14% per year).
Earnings vs Industry: OMED earnings growth over the past year (1.9%) exceeded the Medical Equipment industry -1.1%.
Return on Equity
High ROE: OMED's Return on Equity (12.2%) is considered low.